Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 2011

View Archived Issues

Incozen and Rhizen Pharmaceutical design new CRAC inhibitors

Achaogen presents novel antibacterial aminoglycosides

T cells transduced with GD2-specific receptor 14.G2aCD28zeta lyse Ewing sarcoma cells in vitro

Water-soluble ciclosporin derivative modulates immune responses in dry eye disease

FDA approves Afinitor to treat advanced pancreatic neuroendocrine tumors

Safety monitoring committee finds no significant concerns in Nymox's two pivotal trials of NX-1207

Pfizer discovers potent and selective inhibitors of phosphodiesterase 8B

Erythropoietin-derived peptide pHBSP has anti-inflammatory effects in rodent models of retinopathy

Interim phase I/II data suggest MP-0112 is efficacious in AMD and DME

Chugai Pharmaceutical reflects on first quarter of 2011

Zafgen claims novel methionine aminopeptidase 2 inhibitors

Siena Biotech patents new Wnt signaling inhibitors

Bristol-Myers Squibb divulges new inhibitors of HIV integrase

New IDO-1 inhibitors identified for cancer therapy

Concert Pharmaceuticals' C-10068 has anticonvulsant and neuroprotective activity

PMX-30063 shows in vitro activity against NDM-1-producing drug-resistant bacteria

Intercell begins confirmatory trial of vaccine enhancement patch in pandemic influenza

Dainippon Sumitomo Pharma sets Japanese launch date for Surepost

European phase III Diamyd trial in type 1 diabetes does not meet primary endpoint

Chugai seeks approval for new indications of Herceptin in Japan

Pfizer returns R-343 rights to Rigel Pharmaceuticals

Axcan Pharma/Eurand changes name to Aptalis Pharma

Alkermes and Elan Drug Technologies to merge to form new company

TGen licenses selective histone deacetylase inhibitors to Oncoholdings

EMA agrees to pediatric investigational plan for rFIXFc in hemophilia B

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026